Eligibility Criteria The primary conditions for which semaglutide is prescribed are type 2 diabetes and obesity
In the STEP 1 extension trial, participants regained approximately two-thirds of their weight loss after stopping semaglutide
Lancet 389 , 13991409 (2017)
Tracking changes in weight, appetite, and energy can also help measure effectiveness
The Endocrine Society, whose members include scientists and physicians dedicated to hormone research and treatment for hormone-related conditions, says studies have shown that weight loss medications like semaglutide and tirzepatide improve body composition by reducing excess body fat and increasing the proportion of lean body mass
If your insurance has coverage for weight loss, you should consult with your primary care physician for treatment